Picture of Lineage Cell Therapeutics logo

LCTX — Lineage Cell Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: Lineage Cell Therapeutics Reports First Quarter Results

May 7 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE CELL THERAPEUTICS REPORTS FIRST QUARTER 2020
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * Q1 REVENUE $500,000 VERSUS $900,000
    * Q1 REVENUE ESTIMATE $711,000 -- REFINITIV IBES DATA
    * ANTICIPATE OUR NET OPERATIONAL SPEND FOR 2020 WILL
INCREASE
MODESTLY
    * QTRLY LOSS PER SHARE $0.06

Source text for Eikon:  ID:nBwdnmlMa 
Further company coverage:  LCTX.A 

 ((Briefs@thomsonreuters.com;))

Recent news on Lineage Cell Therapeutics

See all news